New Cancer Procedure Gifts Bay Area Couple 3 More Years Together

Based on results of early studies highlighted by this patient’s and other patients’ experiences, RenovoRx initiated and is currently enrolling Stage 3 pancreatic cancer patients in the TIGeR-PaC clinical trial to further test this promising new procedure for pancreatic cancer patients.

View the entire article on NBC Bay Area

* Individual results may vary.

RenovoRx is participating in clinical trials and the FDA has not determined the safety and or efficacy of its clinical drug development program.